Skip to main navigation Skip to search Skip to main content

Expression of WT1 gene in acute leukemia and its clinical significance

  • Wan hong Zhao
  • , Shan Meng
  • , Xin Meng
  • , Xing mei Cao
  • , Yin xia Chen
  • , Ai li He
  • , Jie Liu
  • , Xiao rong Ma
  • , Wang gang Zhang
  • Xi'an Jiaotong University

Research output: Contribution to journal › Article › peer-review

Abstract

Objective To investigate the expression level and clinical significance of WT1 gene in acute luekemia (AL) patients. Methods WT1 gene level was detected by real time quantitative-polymerase chain reaction in acute myelogenous leukemia (AML) and in acute lymphocytic leukemia (ALL) patients. Then the expression levels of WT1 gene in different subtypes of AML were compared, and the correlation between gene expression and disease courses and prognosis were observed. Moreover, the relationship between disease courses and WT1 expression in patiens after receiving haemopoietic stem cell transplantation were analyzed. Results Among 66 cases, WT1 expression positive rate was 87.5 % (14/16) in AML and 76.0 % (38/50) in ALL. In AML, the expression level in M3 showed the lowest than that in any other subtypes (compared with M1, M2, M4, M5, P value was 0.040, 0.007, 0.006 and 0.01, respectively). The expression level of WT1 was closely correlated with leukemia disease courses. The expression level in complete remission (CR) group showed a significant lower expression level than that in non-remission group (P = 0.018) and relapse group (P = 0.003), and the re-increase of WT1 expression level could predict relapse as early as 1.5 months. Moreover, WT1 expression also showed an close relationship with prognosis of patients receiving haemopoietic stem cell transplantation. Patients whose WT1 was undetectable had a better prognosis than those with persistent expression, and increase again after becoming undetectable. Conclusion WT1 has a high expression level in AL, which can represent minimal residual disease. The expression level in M3 was lowest than that in different AML subtypes, and its expression level has a close correlation with clinical disease course and prognosis of AL.

Original languageEnglish
Pages (from-to)107-110
Number of pages4
JournalJournal of Leukemia and Lymphoma
Volume22
Issue number2
DOIs
StatePublished - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Acute
  • Gene
  • Leukemia
  • Minimal residual disease
  • Reverse transcriptase polymerase chain reaction
  • WT1

Fingerprint

Dive into the research topics of 'Expression of WT1 gene in acute leukemia and its clinical significance'. Together they form a unique fingerprint.

Cite this